Lph.Bk
LPH.BK operates in the healthcare sector, primarily engaged in pharmaceuticals, and generates revenue through the provision of healthcare services and equipment.
Business. LPH.BK operates in the healthcare sector, primarily engaged in pharmaceuticals, and generates revenue through the provision of healthcare services and equipment.
At a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
LPH.BK operates in the healthcare sector, primarily engaged in pharmaceuticals, and generates revenue through the provision of healthcare services and equipment.
LPH.BK maintains a conservative capital structure with a debt-to-equity ratio of 0.19, indicating a relatively low reliance on debt financing. The company's liquidity position is characterized as medium, with a current ratio of 1.54, suggesting it has sufficient short-term assets to cover its short-term liabilities. However, the company's net cash position is negative after subtracting total debt, which may signal potential liquidity constraints.
In terms of profitability, LPH.BK reports a return on equity (ROE) of 10.02% and a return on assets (ROA) of 6.68%. These figures are indicative of the company's ability to generate returns from its equity and total assets, respectively. The ROE is a key metric for assessing the efficiency of equity usage, while the ROA reflects the company's overall asset utilization efficiency.
LPH.BK's revenue is primarily derived from its operations in the healthcare sector, with a focus on pharmaceuticals. The company's geographic exposure is not explicitly detailed in the provided data, but its operations are centered around the provision of healthcare services and equipment. The company's revenue concentration is not specified, but its primary business activity is in the pharmaceuticals segment.
The growth trajectory of LPH.BK is not explicitly detailed in the provided data. However, the company's operating cash flow of 531,218,850 THB and free cash flow of 201,406,510 THB suggest a positive cash flow generation capability, which is essential for sustaining and potentially expanding operations. The capital expenditure of -132,893,530 THB indicates that the company is investing in its operations, which could support future growth.
The risk assessment for LPH.BK highlights a medium liquidity risk and a low dilution risk. The company's liquidity risk is primarily due to its negative net cash position after accounting for total debt, which could affect its ability to meet short-term obligations. The dilution risk is low, indicating that the company is not expected to issue additional shares that could dilute existing shareholders' equity in the near term.
Recent events related to LPH.BK are not explicitly detailed in the provided data. However, the company's financial performance and risk profile suggest that it is maintaining a stable position in the healthcare sector. The company's financial statements and risk assessment provide a comprehensive view of its current financial health and potential future challenges.
- LPH.BK maintains a conservative capital structure with a low debt-to-equity ratio of 0.19.
- The company's return on equity (ROE) of 10.02% and return on assets (ROA) of 6.68% indicate strong profitability.
- LPH.BK's liquidity position is characterized as medium, with a current ratio of 1.54.
- The company's negative net cash position after subtracting total debt may signal potential liquidity constraints.
- LPH.BK's operating cash flow and free cash flow suggest a positive cash flow generation capability.
- The company's dilution risk is low, indicating a stable equity position.
- **margin_outlook_rationale**: The company's gross profit margin is expected to remain stable due to consistent revenue and cost management.
Bull / Bear case
analysis pipelineIn focus — financials by report
Valuation
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
Options
Short squeeze
Earnings-call key lines
Estimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
- Net cash is negative after subtracting total debt.
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Net Cashcash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
- Capex To Revenuecapital_expenditure / revenue
- Return On Equitynet_income / total_equity
- Debt To Equity(short_term_debt + long_term_debt) / total_equity
- Cash Conversion Ratiooperating_cash_flow / net_income
- LPH.BK Market data — financials · 2026-05-28
Ownership & reference
Leadership
- Angkul ChantanawanitChief Executive Officer, Executive Director